Table 2. Demographic and clinical characteristics of PD and control group for the long-term retention session.
PD (n = 6) | CG (n = 7) | |||||
Variable | M | SD | Range | M | SD | Range |
Age | 62 | 11.33 | 46–79 | 68 | 9.1 | 53–80 |
Duration of PD in years | 5 | 0.9 | 4–6 | |||
UPDRS motor score | 24 | 6.7 | 16–44 | |||
H&Y | 2–3 | |||||
MMSE | 28.8 | 1.5 | 26–30 | 28 | 1.3 | 26–30 |
Medication (mg): | ||||||
Levodopa (n = 6) | 439.6 | 247.8 | 187.5–900 | |||
Carbidopa (n = 6) | 105.8 | 61.5 | 47–225 | |||
Entacapon (n = 2) | 900 | 424.3 | 600–1200 |